Related references
Note: Only part of the references are listed.Repeated Adjuvant Anti-CEA Radioimmunotherapy After Resection of Colorectal Liver Metastases: Safety, Feasibility, and Long-Term Efficacy Results of a Prospective Phase 2 Study
Carsten-O. Sahlmann et al.
CANCER (2017)
German Multicenter Study Investigating 177Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients
Kambiz Rahbar et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Safety of multiple repeated cycles of 177Lu-octreotate in patients with recurrent neuroendocrine tumour
Anna Yordanova et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
The impact of repeated cycles of radioligand therapy using [177Lu] Lu-PSMA-617 on renal function in patients with hormone refractory metastatic prostate cancer
Anna Yordanova et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
Overall survival and response pattern of castration-resistant metastatic prostate cancer to multiple cycles of radioligand therapy using [177Lu]Lu-PSMA-617
Hojjat Ahmadzadehfar et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
Radioligand therapy of metastatic prostate cancer using 177Lu-PSMA-617 after radiation exposure to 223Ra-dichloride
Hojjat Ahmadzadehfar et al.
ONCOTARGET (2017)
CXCR4-directed endoradiotherapy induces high response rates in extramedullary relapsed Multiple Myeloma
Constantin Lapa et al.
THERANOSTICS (2017)
In Vitro and In Vivo Efficacy of a Novel CD33-Targeted Thorium-227 Conjugate for the Treatment of Acute Myeloid Leukemia
Urs B. Hagemann et al.
MOLECULAR CANCER THERAPEUTICS (2016)
90Y Hepatic Radioembolization: An Update on Current Practice and Recent Developments
Arthur J. A. T. Braat et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Early side effects and first results of radioligand therapy with 177Lu-DKFZ-617 PSMA of castrate-resistant metastatic prostate cancer: a two-centre study
Hojjat Ahmadzadehfar et al.
EJNMMI RESEARCH (2015)
Radiopharmaceutical Therapy of Patients with Metastasized Melanoma with the Melanin-Binding Benzamide I-131-BA52
Walter Mier et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Yttrium-labelled peptides for therapy of NET
Lisa Bodei et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
Internal radiotherapy of painful bone metastases
K. Liepe et al.
METHODS (2011)
Randomised Phase I/II trial assessing the safety and efficacy of radiolabelled anti-carcinoembryonic antigen I131 KAb201 antibodies given intra-arterially or intravenously in patients with unresectable pancreatic adenocarcinoma
Asma Sultana et al.
BMC CANCER (2009)
EANM procedure guideline for radio-immunotherapy for B-cell lymphoma with 90Y-radiolabelled ibritumomab tiuxetan (Zevalin)
Jan Tennvall et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2007)
Share Paper
